Ravikirti et al. 2021. Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India. Journal of Pharmacy & Pharmaceutical Sciences. 24, 3 (Jul. 2021), 343–350. DOI:https://doi.org/10.18433/jpps32105.